Bills · HR 6897
IN COMMITTEE· 119TH CONGRESS
House BillHR 6897Health
Thyroid Disease CARE Act of 2025
INTRO DEC 18· LAST ACTION DEC 18
READING
7MIN
COSPONSORS
1
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThyroid disease, including conditions like hypothyroidism, hyperthyroidism, and thyroid cancer, affects millions of Americans and can lead to a wide range of debilitating symptoms if not properly diagnosed and treated. This bill matters because it would direct significant federal resources toward closing critical knowledge gaps about these conditions, potentially leading to earlier diagnoses, more effective treatments, and better quality of life for patients.
Without this bill, research efforts might remain fragmented, disparities in care for different populations could persist, and public awareness about thyroid disease symptoms and treatment options might not improve significantly. If passed, it could lead to tangible improvements in public health by fostering medical advancements, promoting health equity by addressing disproportionate impacts, and empowering individuals to recognize and seek help for thyroid issues.
KEY PROVISIONS
5AI-extractedPROVISION 01
Requires the Secretary of Health and Human Services to conduct or support extensive research into thyroid disease, including its root causes, improved diagnostics and treatments, and enhanced thyroid cancer care and survivorship.
This provision directly addresses fundamental gaps in scientific understanding, which is crucial for developing better medical interventions.
PROVISION 02
Mandates an analysis of research gaps and the disproportionate impacts of thyroid disease on various demographic groups, with a focus on women, including examining barriers to care and healthcare professional knowledge.
This will help identify and address inequities in healthcare access and outcomes for different populations suffering from thyroid disease.
PROVISION 03
Directs the creation of a public awareness campaign to educate the public on thyroid disease incidence, symptoms, treatment options, and the disparities in its impact, particularly on women.
Increased public awareness can lead to earlier detection and better patient outcomes by helping individuals recognize symptoms and seek appropriate medical care.
PROVISION 04
Authorizes $30,000,000 for each of fiscal years 2026 through 2030 for thyroid disease research.
This provides dedicated, substantial funding necessary to carry out the mandated research activities over several years.
PROVISION 05
Authorizes $30,000,000 for each of fiscal years 2026 through 2030 for analyzing research gaps and disproportionate impacts of thyroid disease.
This ensures dedicated funding to conduct a thorough analysis of healthcare disparities and barriers, which is essential for developing targeted solutions.
SPONSORSHIP
1 + 1
D· Michigan
YRS IN OFFICE
7
BILLS LED
59
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 1 REP 0 IND 0
ACTION TIMELINE
2 EVENTSDEC 18
Introduced in House
DEC 18
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 6897
Congress119th
StatusIn Committee
IntroducedDec 18, 2025
Last actionDec 18, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED DEC 18, 2025
House BillHR 6897Health
Thyroid Disease CARE Act of 2025
INTRODUCED DEC 18, 2025· LAST ACTION DEC 18, 2025
PASSAGE CHANCES
—%
READING
7 min
COSPONSORS
1
COMPLEXITY
Moderate
